About
aap Implantate AG is a medical technology company based in Berlin, Germany, focused on developing, producing, and marketing medical implants for orthopaedics, particularly for treating fractures and trauma. Established in 1990, the company is publicly traded on the Frankfurt Stock Exchange. The company's key product is the LOQTEQ® anatomical plating system, which enhances surgical outcomes with anatomically optimized implants. aap Implantate AG also manufactures a variety of cannulated screws and is innovating with technologies like antibacterial silver coatings and magnesium-based implants. The company manages the entire value chain from development to sales, distributing its products globally through direct sales in Germany and a network of distributors in around 25 countries. In the U.S., it operates through its subsidiary, aap Implants Inc., utilizing a hybrid distribution model. aap Implantate AG serves hospitals, clinics, and healthcare providers specializing in orthopaedic trauma care and collaborates with global partners for product distribution. The company includes several subsidiaries and holds a minority stake in AEQUOS Endoprothetik GmbH.
Technologies
Keywords
Company Information
-
Employees 87
-
Founded 1990
-
Annual Revenue $12713000
-
Total Funding $1051703
Location
5 Lorenzweg, Berlin, Berlin, Germany, 12099